X Bibli
X Bibli
X Bibli
DOI: 10.22592/ode2018n31a8
Abstract
Basal cell adenocarcinoma is an epithelial neoplasm with the cytological characteristics of basal
cell adenoma but with a morphological pattern of infiltrative growth indicative of malignancy.
Due to its low incidence it is often difficult to diagnose a basal cell adenocarcinoma. The
objective of the present study was to identify morphological and immunohistochemical
characteristics that contribute to its diagnosis. A parotid tumor was resected in a 52-year-old
patient; postoperative biopsy and immunostaining with Ki-67, CK19, p63 and alpha- smooth
muscle actin were performed. It was diagnosed basal cell adenocarcinoma that invades the
tumor capsule, periglandular fat and lymph nodes. Immunostaining with Ki-67, CK19, p63
and alpha- smooth muscle actin was positive. Subsequently, a maxillary sinus metastasis
was diagnosed. The morphological characteristics, Ki-67 expression strongly positive and
metastasis give the malignant character to this tumor, which differentiates it from the basal
cell adenoma.
1 Medical Doctor - Clinical Oncology Specialist. Assistant Professor. School of Medical Sciences. Universidad Nacional de Córdoba.
Argentina. ORCID: 0000-0001-5268-2339
2 Doctor of Medicine and Surgery. Associate Professor. School of Medical Sciences. Universidad Nacional de Córdoba. Argentina.
ORCID: 0000-0001-8857-2406
3 Doctor of Medicine and Surgery. Full Professor. School of Dentistry. Universidad Nacional de Córdoba. Argentina. ORCID: 0000-
0002-6093-3297
Case report of Basal cell adenocarcinoma of the parotid gland: clinicopathological and immunohistochemical study
73
The radiation therapy scheme could not be
completed; palliative care was continued until
her death two months later.
Discussion
Primary basaloid tumors of the salivary glands
are lesions characterized by a predominance of
“basaloid” epithelial cells with round or ovoid
nuclei surrounded by a thin cytoplasm. The
term “basaloid epithelial cells” arose from ob-
Fig. 3: IMMUNOHISTOCHEMICAL LABELING
servations with standard histological techniques
OF BASAL CELL ADENOCARCINOMA
The arrow shows the nuclei of myoepithelial cells that do not make it possible to distinguish if
positive for p63. 400x. there are myoepithelial or ductal or basal epi-
The arrow indicates the nuclei of the epithelial cells thelial cells. In these cases, immunohistochem-
positively labeled for ical labeling is a useful tool to detect both cell
Ki-67. 400x. types, since it improves diagnostic accuracy.
The immunohistochemistry panel used in the
Given the results of the histopathological study, case described (p63, α-smooth muscle actin
the patient was referred for oncological treat- and CK19) was important for the diagnosis of
ment, with indication of postoperative radio- the “basaloid” cells of this carcinoma(9,10).
therapy for six weeks, which began in March The heterogeneous tumoral group of basaloid
2004. The treatment plan included the irradia- epithelial cells includes benign tumors such as
tion of the parotid plus the cervical region left pleomorphic adenoma, and basal cell adenoma,
at a total dose of 60 Gy, with a daily dose of and malignant tumors such as adenoid cystic
2 Gy. The complications were mucositis, dys-
carcinoma, undifferentiated small cell carcino-
phagia and mycosis, which, upon receiving
ma, and basal cell adenocarcinoma(10,11).
specific treatment, improved at the end of the
Basal cell adenocarcinoma mainly affects the
radiotherapy sessions.
parotid gland (more than 90%) and is histolog-
In September 2004, an orthopantomography
ically similar to basal cell adenoma. However, it
showed a cyst in the left horizontal ramus of
presents an infiltrating growth and a low inci-
the mandible and a vegetative image in the ho-
molateral piriform sinus. The surgery was per- dence of metastasis(1,2,12).
formed and the biopsy was negative for malig- It is generally considered a carcinoma of low
nancy. degree of malignancy, locally destructive and
Subsequently, in March 2005, the pain in the with frequent recurrences. The recurrence peri-
hard palate and the left region of the maxilla od varies from six months to two years and only
began. A CAT scan was indicated and a lesion occasionally produces distant metastases(12,13).
was identified at the maxillary floor level. The In this case the evolution was atypical, present-
surgery was performed and metastasis was di- ed a bone metastasis in an early form, less than
agnosed in the floor of the maxillary sinus. A a year after the end of its treatment. This led to
new radiotherapy plan was indicated, which the deterioration of the general condition of the
had mucositis and dysphagia as complications. patient and her death. This can be explained by
The general condition of the patient worsened the late diagnosis of the lesion, with lymphoid
and she presented dehydration and drowsiness. node metastasis; and histological factors of
Case report of Basal cell adenocarcinoma of the parotid gland: clinicopathological and immunohistochemical study
75
For the primary treatment of the tumor, when 3. World Health Organization. International clas-
it originates in the minor salivary glands, some sification of diseases for oncology (ICD-O) –
authors consider that surgical excision should 3rd ed. Malta. WHO, 2003. 252p:
be wide to ensure its complete removal(20). 4. Samar ME, Avila RE. Glosario de histopa-
tología: tumores epiteliales de las glándulas
In addition, there is no agreement on the role
salivales. 2nd ed. Córdoba. Samar ediciones,
of radiotherapy. However, postoperative radio-
2015. 96p:
therapy is recommended in the case of surgeries 5. Sarafraz Z, Azaraein MH, Moghimi M, Musa-
with positive surgical margins or surgical exci- vi SA. Basal cell adenocarcinoma of the parotid
sion of recurrent tumors(21,22). gland in an elderly Iranian woman and review
of the literature. Otolaryngol (Sunnyvale) 2015;
5: doi: 10.4172/2161-119X.1000180.
Conclusions 6. Ward BK, Seethala RR, Barnes EL, Lai SY. Bas-
al cell adenocarcinoma of a hard palate minor
Epithelial and myoepithelial cells coexist in
salivary gland: case report and review of the lit-
the basal cell adenocarcinoma of the salivary erature. Head Neck Oncol. 2009; 1: 41. doi:
glands, identified through immunohistochem- 10.1186/1758-3284-1-41.
ical markers. 7. Jung MJ, Roh JL, Choi SH, Nam SY, Kim SY,
It is essential to obtain histological sections of Lee S. Basal cell adenocarcinoma of the sali-
the tumor interface with the normal gland or vary gland: a morphological and histochemical
with the surrounding fat to evaluate tumor in- comparison with basal cell adenoma with and
vasion. without capsular invasion. Diag Pathol 2013; 8:
Capsular, perineural and periparotid adipose 171. doi:10.1186/1746-1596-8-171.
tissue invasion, Ki‑67 positive immunolabeling 8. Thotakura M, Tirumalasetti N, Krishna R. Role
of Ki-67 labeling index as an adjunct to the his-
with a proliferative index of 25% and metas-
topathological diagnosis and grading of astro-
tasis in a regional lymphoid node and in the cytomas. J Cancer Res Ther 2014; 10: 641-5.
maxillary sinus are factors of poor prognosis 9. Seethala RR. Basaloid/blue salivary gland tu-
that, associated with late diagnosis, explain the mors. Modern Pathol 2017; 30: S84-S95:
unfavorable evolution of the patient. 10. Samar ME, Avila RE, Fonseca I, Ferraris RV,
Although it is a tumor with local aggressiveness Rabino ZM. Adenoma de células basales de
and low incidence of metastasis, early diagnosis glándulas salivales, variedades sólido y tubular:
and early oncological care are of crucial impor- estudio histopatológico e inmunohistoquímico.
tance to give these patients a greater chance for Patología Rev Latinoam 2008; 46 (3): 276-83.
a cure. 11. Chhieng DC, Paulino AF. Basaloid tumors of
the salivary glands. Ann Diag Pathol 2002; 6:
364-72.
References 12. Zhan KY, Leutsch EJ. Basal cell adenocarci-
noma of the major salivary glands: a popula-
1. Eveson JW. WHO histological classification tion-level study of 509 cases. Laryngoscope
of tumours of the salivary glands. In: Barnes 2016; 126 (5): 1089-90.
I, Eveson JW, Reichart P, Sidransky D editors. 13. Chen S, Yang S, Cheu X. Basal cell adenocar-
World Health Organization, classification of cinoma of the buccal minor salivary gland with
tumours, pathology and genetics of head and liver metastasis. An Saudi Med 2015; 35 (4):
neck tumours. Lyon: IARC Press, 2005. 318-20.
2. Ellis GL, Auclair PL. Atlas of tumor pathology: 14. Sulakshana MS, Deepti SF, Dayananda BS.
Tumors of the major salivary glands. 4 serie. Is- Basal cell adenocarcinoma of the salivary gland.
sue 9. Washington DC. Armed Forces Institute A rare entity. IAIM 2015; 2/5: 156-9.
of Pathology (AFIP). 2008.
Case report of Basal cell adenocarcinoma of the parotid gland: clinicopathological and immunohistochemical study
77